Insight Molecular Diagnostics IncIMDX
Price$3.47

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.7M-11.2% YoYTTM through 30 Jun 2026
Net Income -$49.4MTTM through 30 Jun 2026
Free Cash Flow -$31MTTM through 30 Jun 2026

Margins

Current
Gross Margin46.9%
Operating Margin-13,671.9%
Net Margin-2,955.6%

Returns

231.7%ROE
-167.6%ROA

Balance Sheet Health

Debt / Equity-0.29x
Current Ratio2.54x
Net Debt-$25.1Mnet cash position
Cash & Equivalents$17.8M

Quality Metrics

Altman Z-Score-23.36
Piotroski F-Score3 / 9
FCF Margin-1,856.2%
Rule of 40-1,804.5
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $4.1M
Diluted EPS-$1.52TTM
'22'23'24'25
FY2025: $-1.65

Dividend

No dividend

Capital Allocation

Capex Intensity234.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.